Skip to main content

Lakewood-Amedex Biotherapeutics Inc.

corporate_fare Company Profile

Lakewood-Amedex Biotherapeutics Inc.

LABT·NASDAQ·Life Sciences·CIK 0002079272

Lakewood-Amedex Biotherapeutics Inc. is a clinical-stage biotechnology company focused on developing antimicrobial products in the United States. The company's primary offerings include products from its Bisphosphocin class, which are a novel type of antimicrobial agents designed to combat infections by disrupting the membranes of microbes. Additionally, Lakewood-Amedex Biotherapeutics Inc. is developing Nu-3, a topical antimicrobial specifically intended for treating infected diabetic foot ulcers. The company, originally incorporated in 2006, was formerly known as Lakewood-Amedex Inc. and adopted its current name, Lakewood-Amedex Biotherapeutics, Inc., in June 2025. Its headquarters are located in University Park, Florida.

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for LABT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for LABT spans 10-Q, 8-K, S-1, DEF 14A.

Recent high-impact activity:

  • Q3 10-Q: Going Concern, $6.2M Nine-Month Loss, Cash Through January 2027
  • Nasdaq Moves to Delist Lakewood-Amedex After Sub-$1 Bid; Hearing Request Is the Only Stay
  • Lakewood-Amedex Pays $1.27M Cash to Retire All Series C Preferred
  • Shareholders Approve 8x Authorized Share Increase and Reverse Split Authority
  • First Patient Dosed in Phase 2a Trial of Nu-3 for Diabetic Foot Ulcers

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 152,917 shares in LABT as of the October 30, 2026 settlement, a 69.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 48.9% of LABT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)152,917 shares as of October 30, 2026
Change vs prior period▲ 69.8%
Days to cover1.00 at avg daily volume of 6,760,367
Daily short volume (FINRA facilities)48.9% of 16,388,927 shares on November 20, 2026
5-day average short volume49.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for LABT, detected from its recent SEC filings · based on capital-structure filings through 2026-05-26.

1 recent capital raise1 shelf registrationreverse split

Massive Dilution Confirmed · Ongoing Going Concern Warning

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with L →
$0.235 -4.04% today
52-week range · as of 2026-11-16 $0.1687 – $98.2
Market cap
$2.19M
Volume
57.7M (1.8× avg)
3-mo avg 32M
Live data · 2026-11-22 04:22 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LABT - Latest Insights

LABT
Nov 16, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.245
Real-time Price: $0.235 info
Change: -$0.010 (-4%) info
Market Cap: $2.192M info
LABT
Nov 16, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.230
Real-time Price: $0.235 info
Change: +$0.0050 (+2%) info
Market Cap: $2.192M info
LABT
Nov 10, 2026, 5:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.402
Real-time Price: $0.235 info
Change: -$0.167 (-42%) info
Market Cap: $2.192M info
LABT
Sep 28, 2026, 5:49 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.235 info
Change: -$0.835 (-78%) info
Market Cap: $2.192M info
LABT
Sep 24, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $0.235 info
Change: -$1.57 (-87%) info
Market Cap: $2.192M info
LABT
Sep 18, 2026, 5:30 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $1.94
Real-time Price: $0.235 info
Change: -$1.71 (-88%) info
Market Cap: $2.192M info
LABT
Aug 13, 2026, 9:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.28
Real-time Price: $0.235 info
Change: -$2.05 (-90%) info
Market Cap: $2.192M info
LABT
Aug 10, 2026, 5:13 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.36
Real-time Price: $0.235 info
Change: -$2.13 (-90%) info
Market Cap: $2.192M info
LABT
Jul 30, 2026, 4:31 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.94
Real-time Price: $0.235 info
Change: -$1.71 (-88%) info
Market Cap: $2.192M info
LABT
Jul 22, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.88
Real-time Price: $0.235 info
Change: -$1.65 (-88%) info
Market Cap: $2.192M info
LABT
Jul 15, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.69
Real-time Price: $0.235 info
Change: -$2.46 (-91%) info
Market Cap: $2.192M info
LABT
Jun 22, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.392
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
Jun 17, 2026, 1:55 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.61685
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
Jun 17, 2026, 11:40 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.744999
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
May 27, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.698
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
May 26, 2026, 4:06 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.727
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
May 22, 2026, 5:01 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.7083
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
May 22, 2026, 4:55 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7022
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
May 18, 2026, 9:20 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
LABT
May 14, 2026, 4:18 PM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $1.98
Real-time Price: $0.235 info
Change: Reverse Stock Split info
Market Cap: $2.192M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets